A Ludwig Cancer Research study has identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert—or ‘de-differentiate’—to...

Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking ‘cell drinking,’ or macropinocytosis, in the thick tissue surrounding a pancreatic...

ProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in mice, according to a study published...